The smart in-vitro fertilization (IVF) lab monitoring market size is expected to see rapid growth in the next few years. It will grow to $0.68 billion in 2030 at a compound annual growth rate (CAGR) of 13.8%. The growth in the forecast period can be attributed to integration of advanced embryo safety protocols in laboratory workflows, increasing regulatory scrutiny and compliance requirements in fertility treatments, growing demand for high precision environmental stability in ivf labs, rising adoption of automated quality assurance frameworks in reproductive medicine, expansion of fertility services in emerging healthcare markets. Major trends in the forecast period include embryo handling standardization and protocol optimization, contamination risk reduction protocols in ivf laboratories, incubator opening frequency minimization practices to maintain stable embryo culture conditions, cryopreservation quality assurance scheduling and lifecycle control, laboratory personnel competency certification and compliance frameworks.
The increasing infertility rates are expected to drive the growth of the smart in-vitro fertilization (IVF) lab monitoring market going forward. Infertility rates refer to the percentage of individuals or couples who are unable to achieve pregnancy after 12 months of regular unprotected sexual intercourse. Infertility rates are rising due to increasing stress levels, as prolonged stress can affect hormonal balance, disrupt ovulation and sperm production, and negatively impact overall reproductive health. Smart in-vitro fertilization (IVF) lab monitoring solutions help address infertility challenges by providing real-time monitoring and accurate control of laboratory conditions, enhancing embryo development, treatment precision, and overall IVF success rates. For instance, in August 2025, according to the Office for National Statistics (ONS), a UK government department, the total fertility rate (TFR) in England and Wales remained at a historic low of 1.41 children per woman in 2024, compared with 1.42 in 2023, indicating a continued decline in fertility rates and increasing infertility-related challenges. Therefore, the increasing infertility rates are driving the growth of the smart in-vitro fertilization (IVF) lab monitoring market.
Major companies operating in the smart in vitro fertilization (IVF) lab monitoring market are focusing on developing advanced monitoring-as-a-service (MaaS) platforms to enhance laboratory safety, optimize workflow efficiency, support regulatory compliance, and improve patient outcomes. A monitoring-as-a-service (MaaS) platform is a cloud-based monitoring solution that delivers real-time visibility, automated notifications, and predictive analytics for critical systems, equipment, and environmental conditions through connected devices and data-driven technologies. For instance, in January 2025, SpOvum Technologies, an India-based IVF technology company, launched its Integrated IVF Management Solution, a monitoring-as-a-service (MaaS) platform designed to transform IVF laboratory operations. The solution includes real-time laboratory health monitoring, smart witness technology, integrated patient data management, automated reporting, and compliance monitoring for assisted reproductive technology (ART) laboratories. The platform enables continuous tracking of essential laboratory parameters, transparent workflow management, electronic witnessing, and immediate alerts, helping IVF clinics improve operational efficiency, minimize errors, maintain quality standards, and enhance patient care outcomes.
In May 2025, SpOvum Technologies Pvt. Ltd., an India-based technology company specializing in assisted reproductive technology (ART) and IVF laboratory automation solutions, partnered with Khushi Fertility & IVF Centre to deploy AI-powered IVF laboratory management systems and smart monitoring solutions aimed at improving embryology precision, operational efficiency, and clinical outcomes. Through this partnership, the companies aim to establish an AI-driven smart IVF ecosystem that enhances laboratory workflows, minimizes human errors, and improves embryo tracking accuracy to support better fertility treatment results. Khushi Fertility & IVF Centre is an India-based assisted reproductive technology (ART) clinic.
Major companies operating in the smart in-vitro fertilization (ivf) lab monitoring market report are ASTEC Co. Ltd., CooperSurgical Inc., Process Sensing Technologies Ltd., Vitrolife AB, Rees Scientific Corporation, Nexpring Health, ELPRO-BUCHS AG, TMRW Life Sciences Inc., LABOTECT GmbH, Shivani Scientific Industries Pvt. Ltd., XiltriX International B.V., IMT International Ltd., Thermo Fisher Scientific, Merck Millipore, Kitazato Corporation.
North America was the dominating region in the smart in-vitro fertilization (IVF) lab monitoring market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the smart in-vitro fertilization (IVF) lab monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the smart in-vitro fertilization (IVF) lab monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Smart In-Vitro Fertilization (IVF) Lab Monitoring Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses smart in-vitro fertilization (ivf) lab monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for smart in-vitro fertilization (ivf) lab monitoring? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart in-vitro fertilization (ivf) lab monitoring market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:
1) By Component: Hardware; Software; Services2) By Deployment Mode: Cloud Based; On Premises
3) By Distribution Channel: Direct Sales; Distributors; Online Sales
4) By Application: Embryo Culture Monitoring; Cryogenic Storage Monitoring; Environmental Condition Monitoring; Sample Tracking And Witnessing; Equipment Performance Monitoring; In Vitro Fertilisation Workflow Management
5) By End User: Fertility Clinics; In Vitro Fertilisation Centers; Hospitals; Embryology Laboratories; Cryobanks; Research And Academic Institutes
Subsegments:
1) By Hardware: Environmental Monitoring Sensors; Temperature Monitoring Devices; Humidity Monitoring Devices; Carbon Dioxide And Oxygen Monitoring Systems; Air Quality And Volatile Organic Compound Sensors2) By Software: In Vitro Fertilisation Laboratory Management Software; Cloud Based Monitoring Platforms; Embryo Monitoring Software; Artificial Intelligence Based Embryo Assessment Software; Data Analytics And Reporting Software
3) By Services: Real Time Monitoring Services; Remote In Vitro Fertilisation Laboratory Monitoring Services; Installation And Integration Services; Calibration And Validation Services; Equipment Maintenance Services
Companies Mentioned: ASTEC Co. Ltd.; CooperSurgical Inc.; Process Sensing Technologies Ltd.; Vitrolife AB; Rees Scientific Corporation; Nexpring Health; ELPRO-BUCHS AG; TMRW Life Sciences Inc.; LABOTECT GmbH; Shivani Scientific Industries Pvt. Ltd.; XiltriX International B.V.; IMT International Ltd.; Thermo Fisher Scientific; Merck Millipore; Kitazato Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentations: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
- ASTEC Co. Ltd.
- CooperSurgical Inc.
- Process Sensing Technologies Ltd.
- Vitrolife AB
- Rees Scientific Corporation
- Nexpring Health
- ELPRO-BUCHS AG
- TMRW Life Sciences Inc.
- LABOTECT GmbH
- Shivani Scientific Industries Pvt. Ltd.
- XiltriX International B.V.
- IMT International Ltd.
- Thermo Fisher Scientific
- Merck Millipore
- Kitazato Corporation

